Literature DB >> 26753962

ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.

Zheng Li1, Xin Yu2, Jianxiong Shen3.   

Abstract

Long non-coding RNAs (lncRNAs) are a family of non-protein-coding RNAs with length more than 200 nucleotides. LncRNAs played important roles in many biological processes such as cell development, proliferation, invasion and migration. Deregulation of LncRNAs was found in multiple tumors where they can act as a tumor suppressor gene or oncogene. LncRNA ANRIL was identified as an oncogene involved in a number of tumors such as gastric cancer, lung cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma. Inhibition of ANRIL suppressed the cancer cell proliferation, migration and invasion. Increasing data has showed that ANRIL may act as a diagnostic and prognostic biomarker for some tumors. In our review, we summarize an overview of current knowledge concerning the expression and role of ANRIL in various cancers.

Entities:  

Keywords:  ANRIL; Cancer; Long non-coding RNAs; lncRNAs

Mesh:

Substances:

Year:  2016        PMID: 26753962     DOI: 10.1007/s13277-016-4808-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  51 in total

Review 1.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

2.  Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.

Authors:  Y Kotake; T Nakagawa; K Kitagawa; S Suzuki; N Liu; M Kitagawa; Y Xiong
Journal:  Oncogene       Date:  2010-12-13       Impact factor: 9.867

3.  CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.

Authors:  Carmen Rodriguez; Julie Borgel; Frank Court; Guy Cathala; Thierry Forné; Jacques Piette
Journal:  Biochem Biophys Res Commun       Date:  2010-01-04       Impact factor: 3.575

4.  ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma.

Authors:  Deyu Chen; Zhaoyue Zhang; Chaoming Mao; Yuepeng Zhou; Lichao Yu; Yue Yin; Shi Wu; Xiao Mou; Yan Zhu
Journal:  Cell Immunol       Date:  2014-04-03       Impact factor: 4.868

Review 5.  Long noncoding RNAs in regulation of human breast cancer.

Authors:  Guangxue Wang; Cuicui Liu; Shengqiong Deng; Qian Zhao; Tieyan Li; Shanshan Qiao; Lei Shen; Yue Zhang; Jinhui Lü; Lingyu Meng; Chunli Liang; Zuoren Yu
Journal:  Brief Funct Genomics       Date:  2015-11-18       Impact factor: 4.241

6.  Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.

Authors:  Ming-de Huang; Wen-ming Chen; Fu-zhen Qi; Rui Xia; Ming Sun; Tong-peng Xu; Li Yin; Er-bao Zhang; Wei De; Yong-qian Shu
Journal:  J Hematol Oncol       Date:  2015-05-14       Impact factor: 17.388

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

Review 8.  A pathophysiological view of the long non-coding RNA world.

Authors:  Federico Di Gesualdo; Sergio Capaccioli; Matteo Lulli
Journal:  Oncotarget       Date:  2014-11-30

Review 9.  The Clinical Relevance of Long Non-Coding RNAs in Cancer.

Authors:  Andreia Silva; Marc Bullock; George Calin
Journal:  Cancers (Basel)       Date:  2015-10-27       Impact factor: 6.639

10.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.

Authors:  Er-bao Zhang; Rong Kong; Dan-dan Yin; Liang-hui You; Ming Sun; Liang Han; Tong-peng Xu; Rui Xia; Jin-song Yang; Wei De; Jin fei Chen
Journal:  Oncotarget       Date:  2014-04-30
View more
  37 in total

1.  Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.

Authors:  Xigang Hu; Huijuan Jiang; Xiaojun Jiang
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

Review 2.  The emerging role of long non-coding RNA in gallbladder cancer pathogenesis.

Authors:  Akanksha Khandelwal; Akshay Malhotra; Manju Jain; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2016-11-25       Impact factor: 4.079

Review 3.  CCAT2: A novel oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Heyi Zheng; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2017-02-28       Impact factor: 6.831

4.  Long Noncoding RNA ANROC on the INK4 Locus Functions to Suppress Cell Proliferation.

Authors:  Yojiro Kotake; Takeshi Tsuruda
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 5.  Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.

Authors:  Dan-Dan Zhou; Xiu-Fen Liu; Cheng-Wei Lu; Om Prakash Pant; Xiao-Dong Liu
Journal:  Cell Prolif       Date:  2017-10-12       Impact factor: 6.831

6.  Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.

Authors:  Fang-Teng Liu; Qi-Zhen Xue; Pei-Qian Zhu; Hong-Liang Luo; Yi Zhang; Tengfei Hao
Journal:  Onco Targets Ther       Date:  2016-07-12       Impact factor: 4.147

Review 7.  Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.

Authors:  Fredy O Beltrán-Anaya; Alberto Cedro-Tanda; Alfredo Hidalgo-Miranda; Sandra L Romero-Cordoba
Journal:  Front Physiol       Date:  2016-08-08       Impact factor: 4.566

Review 8.  Precise long non-coding RNA modulation in visual maintenance and impairment.

Authors:  Peixing Wan; Wenru Su; Yehong Zhuo
Journal:  J Med Genet       Date:  2016-12-21       Impact factor: 6.318

Review 9.  Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases.

Authors:  Fang Li; Xuyang Wen; He Zhang; Xianqun Fan
Journal:  Int J Mol Sci       Date:  2016-03-31       Impact factor: 5.923

Review 10.  Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.

Authors:  Salvatore De Rosa; Biagio Arcidiacono; Eusebio Chiefari; Antonio Brunetti; Ciro Indolfi; Daniela P Foti
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.